Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines
Open Access
- 1 August 2000
- journal article
- basic science
- Published by Wiley in Arthritis & Rheumatism
- Vol. 43 (8) , 1734-1741
- https://doi.org/10.1002/1529-0131(200008)43:8<1734::aid-anr9>3.0.co;2-b
Abstract
Objective Human chondrocytes produce different C‐X‐C and C‐C chemokines under basal conditions and upon activation with proinflammatory cytokines. We investigated whether human chondrocytes also have chemokine receptors and examined the effects of chemokines on chondrocyte activity. Methods The expression of chemokine receptors was determined by immunochemical analysis of frozen sections from normal and osteoarthritic cartilage and by flow cytometry of isolated cells. The messenger RNA expression for chemokine receptors was studied by reverse transcriptase–polymerase chain reaction. Isolated chondrocytes were stimulated with different chemokines, and the responses were evaluated by assaying the release of matrix metalloprotease 3 (MMP‐3) and of the lysosomal enzyme N‐acetyl‐β‐D‐glucosaminidase in the supernatants. Results A wide variety of chemokine receptors (CCR‐1, CCR‐2, CCR‐3, CCR‐5, CXCR‐1, and CXCR‐2) was detected on human chondrocytes. Interaction of these receptors with the corresponding ligands induced the release of MMP‐3. This response was abrogated by pretreatment of the cells with Bordetella pertussis toxin, demonstrating involvement of G proteins of the Gi type. The response decreased in the presence of cycloheximide, indicating dependence on protein synthesis. Chemokines also induced the exocytosis of N‐acetyl‐β‐D‐glucosaminidase, which was prevented by receptor blockage with anti–CCR‐3 and by treatment with B pertussis toxin. Chondrocytes obtained from osteoarthritic tissue showed an increased expression of CCR‐3 and possibly of CXCR‐1, and an augmented release of matrix‐degrading enzymes compared with chondrocytes from normal donors. Conclusion Our findings suggest the existence in human chondrocytes of a novel catabolic pathway, primed by chemokines and their receptors, that leads to the breakdown of cartilage matrix components.Keywords
This publication has 27 references indexed in Scilit:
- Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritisFEBS Letters, 1999
- Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1β production by synovial T cellsClinical and Experimental Immunology, 1995
- Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytesEuropean Journal of Immunology, 1995
- Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis.Journal of Clinical Investigation, 1994
- Induction of synthesis and release of interleukin‐8 from human articular chondrocytes and cartilage explantsArthritis & Rheumatism, 1992
- Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis.Journal of Clinical Investigation, 1992
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991
- Effects of recombinant human IL-I? on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytesInflammation, 1991
- Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide 2Biochemistry, 1991
- Characterization of granulocyte chemotactic activity from human cytokine-stimulated chondrocytes as interleukin 8Cytokine, 1990